Circadian Relationships between Circulating Atrial Natriuretic Peptides and Serum Sodium and Chloride in Healthy Humans

American Journal of Nephrology

Volumn 16, Issue 6, 1996, Pages 462-470

  Sothern, Robert B ^a   Vesely, David L ^b   Kanabrocki, Eugene L ^c   Bremner, Fraser W ^f   Third, Jane L H C ^f   McCormick, James B ^g   Dawson, Susan ^g   Ryan, May ^d   Greco, Joseph ^c   Bean, Jeff T ^c   Nemchausky, Bernard M ^e   Shirazi, Parvez ^c   Scheving, Lawrence E ^h  

^a REGIONS HOSPITAL   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c Nuclear Medicine   (United States)

^d Nursing Service   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^g Swedish Covenant Hospital   (Italy)

^h UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Atrial natriuretic peptides; Chloride; Circadian rhythm; Sodium

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CHLORIDE ION; SODIUM ION;

ADULT; AGED; ARTICLE; CHLORIDE BLOOD LEVEL; CIRCADIAN RHYTHM; HUMAN; HUMAN EXPERIMENT; MALE; NATRIURESIS; NORMAL HUMAN; PRIORITY JOURNAL; SODIUM BLOOD LEVEL;

EID: 10544233781     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000169045     Document Type: Article

References (33)

1. Vesely DL: Inappropriate secretion of antidi-urctic hormone: in Schwartz GR, Cayten CG. Mangcisen MA. Mayer TA, Hanke BK (eds): Principles and Practice of Emergency Medicine. eds. Philadelphia. Lea & Febiger, 1992. pp 2106-2111.
2. Dananbcrg J: Fluids and electrolytes; in Schwartz GR. Cayten CG. Mangelsen MA. Mayer TA. Hanke BK (eds): Principles and Practice of Emergency Medicine, ed 3. Philadelphia, Lea & Febiger, 1992, pp 2053-2054.
3. Stein JH. Kunau RT Jr. Fried TA: Principles of renal physiology; in Stein JH (cd): Internal Medicine, ed 3. Boston, Little. Brown. 1990. pp 753-758.
4. DeBold AJ, Borenstein HB, Vcress AT, Son-nenberg H: A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981;28:89-94.
5. Currie MG. Geller DM. Cole BR. Boylen JG, YuSheng W, Holmberg SW, Needlentan P: Bioactive cardiac substances: Potent vasorelaxant activity in mammalian atria. Science 1983; 221:71-73.
6. John SWM. Krege JH. Oliver PM, Hagaman JR. Hodgin JR. Pang SC, Flynn TG. Smithies O: Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 1995;267:679-681.
7. Espiner EA, Crozier IG, Nicholls MG. Cuneo R. Ikaram H: Cardiorenal secretion of atrial natriuretic peptide. Lancet 1985:ii:398-399.
8. Vari RC, Freeman RH. Davis JO, Villareal D, Verbürg KM: Effect of synthetic atrial natriuretic factor on aldosterone secretion in the rat. Am J Physiol 1986;251:R48-R52.
9. Anderson JV, Strulhers AD, Payne NN, Slater JDH, Bloom SR: Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man. Clin Sci 1986:70:507-512.
10. Takagi M. Franco-Saenz R, Mulrow PJ: Effect of atrial natriuretic factor on the plasma aldosterone response to potassium infusion in rats: In vivo study. Life Sci 1986:39:359-364.
11. Samson WK: Atrial natriuretic factor inhibits dehydration and hemorrhage-induced vasopressin release. Neuroendocrinology 1985:40: 277-279.
12. Cogan MG: Atrial natriuretic factor can increase renal solute excretion primarily by raising glomerular filtration. Am J Physiol 1986; 250:F710-F714.
13. Vesely DL. Norris JS. Walters JM. Jespersen RR. Baeyens DA: Atrial natriuretic prohormone peptides 1-30.31-67, and 79-98 vasodilate the aorta. Biochcm Biophys Res Commun 1988;150:231-236.
14. Martin DM. Pevahousc JB, Trigg DJ. Vesely DL. Buerkcrt JE: Three peptides from the ANF prohormone NIT-tcrminus are natriuretic and/or kaliuretic. Am J Physiol 1990:258: F1401-F1408.
15. Vesely DL. Douglass MA. Dietz JR. Giordano AT. McCormick MT, Rodriguez-Paz G. Schocken DD: Negative feedback of atrial natriuretic peptides. J Clin Endocrinol Mctab 1994:78:1128-1134.
16. Vesely DL. Douglass MA, Dietz JR. Gower WR Jr, McCormick MT, Rodriguez-Paz G. Schocken DD: Three peptides from the atrial natriuretic factor prohormonc amino terminus lower blood pressure and produce a diuresis, natriuresis, and/or kaliuresis in humans. Circulation 1994;90:1129-1140.
17. Vesely DL. Chiou S. Douglass MA, McCormick MT, Rodriguez-Paz G. Schocken DD: Kaliuretic peptide and long-acting natriuretic peptide as well as atrial natriuretic factor inhibit aldosterone secretion. J Endocrinol 1995: 146:373-380.
18. Gower WR Jr. Chiou S. Skolnick K. Vesely DL: Molecular forms of circulating atrial natriuretic peptides in human plasma and their metabolites. Peptides 1994;15:861-867.
19. Vesely DL, Norsk P, Winters CJ. Rico DM, Sallman AL, Epstein M: Increased release of the N-terminal and C-terminal portions of the prohormone of atrial natriuretic factor during immersion-induced central hypervolemia in normal humans. Proc Soc Exp Biol Med 1989; 192:230-235.
20. Dietz JR, Nazian SJ. Vesely DL: Release of ANF, proANF 1-98. and proANF 31-67 from isolated rat atria by atrial distension. Am J Physiol 1991;260:H1774-H1778.
21. Winters CJ. Sallman AL, Vesely DL: Circadian rhythm of prohormonc atrial natriuretic peptides 1-30. 31-67, and 99-126 in man. Chro-nobiol Int 1988:5:403-409.
22. Vesely DL. Kanabrocki EL. Sothern RB. Schcving LE. Tsai TH. Greco J. Bushnell DL. Kaplan E. Rumbyrt J. Sturtcvant RP. Sturte-vanl FM. Bremner WF. Third JLHC. Hrushe-sky WJM. Olwin JH: The circadian rhythm of the N-terminus and C-terminus of the atrial natriuretic factor prohormonc. Chronobiol Int 1990;7:51-57.
23. Minors DS. Waterhouse JM: Circadian rhythms of urinary excretion: The relationship between the amount excreted and the circadian changes. J Physiol (Lond) 1982;327:39-51.
24. Boemke W. Palm, Corea M, Sccligcr E. Reinhardt HW: Endogenous variations and sodium intake-dependent components of diurnal sodium excretion patterns in dogs. J Physiol (Lond) 1994:476:547-552.
25. Haus E. Nicolau GY, Lakatua D. Sackctl-Lun-deen L: Reference values for chronopharmaco-logy: in Reinberg A. Smolensky M, Labrecquc G (eds): Annual Review of Chronopharmacolo-gy. Oxford, Pergamon Press, 1988. vol 4, pp 333-424.
26. Kanabrocki EL, Sothern RB. Scheving LE. Vesely DL, Tsai TH. Shelstad J, Coumoyer C. Greco J. Mermall H. Nemchausky BM, Bushnell DL, Kaplan E, Kahn S, Augustine G, Holmes E, Rumbyrt J. Sturtcvant RP, Sturte-vant F, Bremner F. Third JLHC. McCormick JB, Mudd CA, Dawson S, Sackett-Lundeen L, HausE, Haiberg F. Pauly JE. Olwin JH: Reference values for circadian rhythms of 98 variables in clinically healthy men in fifth decade of life. Chronobiol lnt 1990:7:445-461.
27. Winters CJ, Sallman AL, Baker BJ. MeadowsJ. Rico DM, Vesely DL: The N-terminus and a 4000 molecular weight peptide from the mid-portion of the N-terminus of the atrial natriuretic factor prohormone each circulate in man and increase in congestive heart failure. Circulation 1989:80:438-449.
28. Haiberg F. Johnson EA. Nelson W, Runge W. Sothern R: Autorhythmomctry: Procedures from physiologic self-measurements and their analysis. Physiol Teach 1972:1:1-11.
29. Bingham C. Arbogast B, Guillaume GC, Lee JK, Haiberg F: Inferential statistical methods for estimating and comparing cosinor parameters. Chronobiologia 1982;9:397-439.
30. Zeidcl ML, Klkeri D, Silva P. Burrowes M, Brenner BM: Atrial natriuretic peptides inhibit conductive Na uptake by rabbit inner medullary collecting duct cells. J Clin Invest 1988:82: 1067-1074.
31. Light DB. Schwiebert EM. Karlson KH, Stanton BA: Atrial natriuretic peptide inhibits a cation channel in renal inner medullary collecting duct cells. Science 1989:243:383-385.
32. 2. J Clin Invest 1992;89:1411-1417.
33. +-ATPase of the atrial natriuretic peptides. Endocrinology 1995:136:2033-2039.